← Back to headlines
J&J’s new psoriasis pill to rival AbbVie’s Skyrizi: BNP Paribas
J&J's new psoriasis pill is expected to compete with AbbVie's Skyrizi, according to BNP Paribas.
Sources
Showing 0 of 1 sources
Related Stories
Kobiety i mężczyźni inaczej reagują na leczenie raka. Nowe badanie
10m ago
Έτσι θα γίνει η ολική απαγόρευση πώλησης καπνού και αλκοόλ σε ανηλίκους -Πώς θα διαπιστώνουν την ηλικία, τα πρόστιμα
14m ago
InspireMD targets $13M–$15M in 2026 revenue as CGuard Prime gains U.S. traction
14m ago
Novids, super-dodgers: The people who have never had Covid
14m ago